Literature DB >> 15140065

On the etiology of contact/occupational vitiligo.

Raymond E Boissy1, Prashiela Manga.   

Abstract

Vitiligo is an acquired depigmentary disorder of the skin that results from the selective destruction of melanocytes, generally during the second decade of life and affecting approximately 1% of the population worldwide. Loss of cutaneous pigment appears to render the skin susceptible to premature aging and cancer. In addition this disease can be socially devastating for afflicted individuals. The etiology of vitiligo is poorly understood. The present dogma suggests that genetic factors render the melanocyte fragile thus predisposing individuals to developing vitiligo. When subjected to instigating factors, these susceptible, fragile melanocytes undergo apoptosis. Autoimmune factors then perpetuate the removal of the melanocyte component from the skin. In the majority of cases the instigating factors are not known (idiopathic vitiligo), however a small sub-set of individuals develop contact/occupational vitiligo following exposure to particular chemicals. Many of these chemicals have been implicated in both contact/occupational vitiligo and chemical leukoderma. Both conditions present with well-defined, depigmented skin lesions that develop following exposure. Only in the case of vitiligo does the depigmentation spread beyond the areas of contact, probably via an immune-mediated mechanism. The largest class of chemicals known to trigger contact/occupational vitiligo is the phenolic/catecholic derivatives. Many have been demonstrated to be preferentially cytotoxic to melanocytes, with high-dose exposure resulting in the initiation of apoptosis. Phenolic/catecholic derivatives are structurally similar to the melanin precursor tyrosine, and therefore tyrosinase was originally implicated as a mediator of cytotoxicity. However, our data suggests that tyrosinase-related protein-1, rather than tyrosinase, facilitates toxicity, possibly by catalytic conversion of the compounds, which results in the generation of radical oxygen species. The ensuing oxidative stress then triggers activation of cellular free radical scavenging pathways to prevent cell death. Genetic inability of melanocytes to tolerate and/or respond to the oxidative stress may underlie the etiology of contact/occupational vitiligo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140065     DOI: 10.1111/j.1600-0749.2004.00130.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  46 in total

1.  4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo.

Authors:  Tara M Kroll; Hemamalini Bommiasamy; Raymond E Boissy; Claudia Hernandez; Brian J Nickoloff; Ruben Mestril; I Caroline Le Poole
Journal:  J Invest Dermatol       Date:  2005-04       Impact factor: 8.551

Review 2.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 3.  Chemical-Induced Vitiligo.

Authors:  John E Harris
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

4.  Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress.

Authors:  Jeffrey A Mosenson; Kelsey Flood; Jared Klarquist; Jonathan M Eby; Amy Koshoffer; Raymond E Boissy; Andreas Overbeck; Rebecca C Tung; I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2014-01-13       Impact factor: 4.693

5.  Chemical Leukoderma Improved by Low-dose Steroid Pulse Therapy.

Authors:  Jae Yoon Jung; Kkot Bora Yeom; Hee Chul Eun
Journal:  Ann Dermatol       Date:  2010-05-19       Impact factor: 1.444

6.  A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo.

Authors:  Prashiela Manga; David Sheyn; Fan Yang; Rangaprasad Sarangarajan; Raymond E Boissy
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

7.  Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG.

Authors:  Jasper G van den Boorn; Debby Konijnenberg; Esther P M Tjin; Daisy I Picavet; Nico J Meeuwenoord; Dmitri V Filippov; J P Wietze van der Veen; Jan D Bos; Cornelis J M Melief; Rosalie M Luiten
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

8.  Chemical leukoderma: what's new on etiopathological and clinical aspects?

Authors:  Sanjay Ghosh
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

9.  Chemical leucoderma: Indian scenario, prognosis, and treatment.

Authors:  A K Bajaj; Abir Saraswat; P K Srivastav
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

10.  Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents.

Authors:  Michaela Brenner; Vincent J Hearing
Journal:  Drug Discov Today Dis Mech       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.